Abera is a Swedish biotech company headquartered in Stockholm, Sweden. Abera is committed to becoming a world-leading company in innovative vaccine technologies. Abera has developed a unique vaccine platform based on Gram-negative bacteria and derived Outer Membrane Vesicles (OMVs) that can be decorated on the surface with multiple antigens of choice at a high density. Abera’s platforms have several unique characteristics as explained on the right.
- Bli medlem
- Om SwedenBIO